Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

Clinical trial NCT04652284 · UNKNOWN

Trial details

NCT number: NCT04652284
Sponsor: Rabin Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Helicobacter Infections Resistance Bacterial Gastritis H Pylori

Start date: 2021-05-01
Primary completion: 2023-05-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.